267 related articles for article (PubMed ID: 9375452)
41. Calcium channel antagonists. What do the second-generation agents have to offer?
Salerno SM; Zugibe FT
Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298
[TBL] [Abstract][Full Text] [Related]
42. [Treatment of angina pectoris with calcium antagonists].
Hopf R; Becker HJ; Kober G; Dowinsky S; Kaltenbach M
Herz; 1982 Aug; 7(4):221-34. PubMed ID: 6751971
[No Abstract] [Full Text] [Related]
43. Calcium blockers in coronary heart disease. Part II.
Pepine CJ; Conti CR
Mod Concepts Cardiovasc Dis; 1981 Dec; 50(12):67-72. PubMed ID: 7339485
[No Abstract] [Full Text] [Related]
44. Clinical use of calcium channel blockers.
Galle JS
Conn Med; 1983 Oct; 47(10):605-10. PubMed ID: 6627936
[No Abstract] [Full Text] [Related]
45. Calcium channel blockers in the management of myocardial infarction patients.
Gheorghiade M
Henry Ford Hosp Med J; 1991; 39(3-4):210-6. PubMed ID: 1804826
[No Abstract] [Full Text] [Related]
46. Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility.
McElmurray JH; Mukherjee R; Patterson TM; Goldberg A; King MK; Hendrick JW; Gay DM; Clair MJ; Jolly JR; Spinale FG
J Card Fail; 2001 Jun; 7(2):158-64. PubMed ID: 11420768
[TBL] [Abstract][Full Text] [Related]
47. [Calcium antagonists in ischemic heart disease].
Sadowski Z; Kośmicki M; Skorykow-Sapińska A
Kardiol Pol; 1987; 30 Suppl():44-9. PubMed ID: 3454384
[No Abstract] [Full Text] [Related]
48. Amelioration of hypertensive heart failure by amlodipine may occur via antioxidative effects.
Hasegawa H; Takano H; Kohro T; Ueda K; Niitsuma Y; Aburatani H; Komuro I
Hypertens Res; 2006 Sep; 29(9):719-29. PubMed ID: 17249528
[TBL] [Abstract][Full Text] [Related]
49. All calcium channel blockers are not alike.
Cheng TO
Int J Cardiol; 1991 Aug; 32(2):267. PubMed ID: 1833347
[No Abstract] [Full Text] [Related]
50. Enhancement of cardioplegic myocardial protection with calcium entry blockers.
Guyton RA; Dorsey LM; Kates RA; Hatcher CR
J Med Assoc Ga; 1984 Oct; 73(10):707-11. PubMed ID: 6502035
[No Abstract] [Full Text] [Related]
51. Use of calcium channel blockers in hypertension.
Conlin PR; Williams GH
Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
[TBL] [Abstract][Full Text] [Related]
52. [Comorbidity in cardiac insufficiency].
Z Kardiol; 1997 Sep; 86(9 Suppl Komor):1-8. PubMed ID: 9373390
[No Abstract] [Full Text] [Related]
53. [Prospects of pharmacologic treatment of post-ischemic heart failure].
Russo R; Rao MA; Romano M; Scotto di Santolo M; Cardei S; Giunta A; Cuocolo A; Volpe M
Cardiologia; 1995 Dec; 40(12 Suppl 1):533-7. PubMed ID: 8998769
[No Abstract] [Full Text] [Related]
54. Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats.
Kaur AH; Singh M; Singh J; Jain K
Indian J Exp Biol; 1985 Jan; 23(1):31-4. PubMed ID: 4018848
[No Abstract] [Full Text] [Related]
55. [Efficacy of diltiazem in uremic hemodialyzed patients with isolated diastolic dysfunction and dialysis hypotensive crisis].
Cice G; Tagliamonte E; Ferrara L; Di Benedetto A; Sorice P; Iacono A
Cardiologia; 1999 Mar; 44(3):289-94. PubMed ID: 10327731
[TBL] [Abstract][Full Text] [Related]
56. A review of calcium channel antagonists in the treatment of pediatric hypertension.
Sahney S
Paediatr Drugs; 2006; 8(6):357-73. PubMed ID: 17154643
[TBL] [Abstract][Full Text] [Related]
57. Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction.
Mahé I; Chassany O; Grenard AS; Caulin C; Bergmann JF
Am J Cardiovasc Drugs; 2003; 3(1):33-41. PubMed ID: 14727944
[TBL] [Abstract][Full Text] [Related]
58. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
Aronow WS
Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
[TBL] [Abstract][Full Text] [Related]
59. Considerations in evaluating new antianginal drugs.
Parisi AF; Strauss WE; McIntyre KM; Sasahara AA
Circulation; 1982 Jan; 65(1 Pt 2):I38-42. PubMed ID: 7030520
[TBL] [Abstract][Full Text] [Related]
60. The unnecessary controversy or lack of knowledge?
Fischer-Hansen J
Eur Heart J; 1997 Jan; 18(1):167-8. PubMed ID: 9049531
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
